Semaglutide in Australia
Ozempic is TGA-approved for type 2 diabetes; Wegovy launched in Australia in August 2024. Off-label private prescribing of Ozempic for weight is legal but PBS does not subsidise weight indication. Australia ran short on Ozempic through 2023-24 due to TGA-managed-supply prioritising T2D patients; Wegovy launch eased pressure but supply remains tighter than tirzepatide.
TGA-registered as Ozempic (T2D, since 2019), Wegovy (weight, August 2024), Rybelsus (oral T2D). Off-label Ozempic-for-weight prescribing legal under Australian medical practice rules. Prescription-only.
What it actually costs.
Midpoint ranges, Eli Lilly brand unless noted. Updated April 2026.
AUD per month on 0.5 to 2.4 mg titration. Telehealth (Juniper, Eucalyptus, Hub Health) dominant.
AUD. PBS doesn't subsidise weight indication; T2D-only PBS price is lower.
AUD on PBS for diabetes-coded patients. Otherwise private cash.
AUD per month. Less common than injectable.
How to get it — on the right side of the line.
Telehealth via Juniper, Eucalyptus, or Hub Health
Australia's dominant GLP-1 telehealth operators. All three do video consults, off-label and on-label prescribing, home delivery to every state.
Private GP with script at a regular pharmacy
If you have a trusted GP, ask for an off-label Ozempic or on-label Wegovy script. Chemist Warehouse and Amcal stock both. Self-pay price is the same as telehealth.
What channels actually work here.
Nationwide via telehealth + pharmacies. Wegovy supply tighter than Ozempic.
Rare post-2025 tightening.
Customs blocks postal import.
Juniper, Eucalyptus, Hub Health dominant.
Australia's 2023-24 Ozempic shortage was severe — TGA prioritised T2D patients and weight-only access dropped to almost zero in some quarters. Wegovy's August 2024 launch eased the pressure considerably. If your priority is reliable supply over price, Wegovy is the steadier choice in 2026. For cost-sensitive patients on stable doses, Thailand-supply round-trip breaks even around 4 months.
Tirzepatide in Australia
Mounjaro / Zepbound — dual GLP-1 + GIP agonist. Eli Lilly. Stronger weight effect head-to-head than semaglutide; also more expensive and supply has been more constrained globally.
Match me to a vendor in Australia.
Two minutes, five questions. Your match email has the vendor name, price, and the honest tradeoff.
We earn a small commission when you buy through recommended vendors. That is how this stays free. Vendors rank by quality signals, not paid placement.